Central coordination for transplant and cell therapy research program
Admin Core
This program brings together teams working on transplant and cell therapies for children and adults with cancer to support lab studies, animal models, and a clinical trial.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Dana-Farber Cancer Inst NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11174466 on NIH RePORTER |
What this research studies
From a patient perspective, this program links basic lab discoveries, preclinical (in vitro and animal) testing, and a clinical trial to move promising cell therapies toward people who need them. The Administrative Core organizes investigators across Dana‑Farber, Children’s Hospital Boston, the University of Minnesota, and other centers, runs meetings, and tracks progress. It also handles fiscal oversight, reporting, and regulatory compliance so the science and trials can run smoothly. That coordination is intended to speed up safe testing of new transplant and cellular approaches for cancer patients, including pediatric transplant populations.
Who could benefit from this research
Good fit: Patients with cancers treated by transplant or cellular therapy programs, including children and adults who are eligible or potentially eligible for a related clinical trial, would be the likely candidates.
Not a fit: People without cancer, those not eligible for transplant or cell therapy trials, or those seeking immediate treatment benefit are unlikely to gain direct benefit from this program.
Why it matters
Potential benefit: If successful, the program could speed development and testing of new transplant and cell therapy options that may lead to safer or more effective cancer treatments.
How similar studies have performed: Related translational programs and early cell therapy trials have shown promising results in some cancers, but many approaches remain experimental and outcomes vary by disease.
Where this research is happening
Boston, United States
- Dana-Farber Cancer Inst — Boston, United States (Active)
Researchers
- Principal investigator: Cutler, Corey S — Dana-Farber Cancer Inst
- Study coordinator: Cutler, Corey S
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.